First Report from Clinical Osteoporosis 2017:
A Joint Conference of the NOF & ISCD

Use of dual-energy X-ray absorptiometry (DXA) for bone age assessment shows similar results when tested against traditional radiology, according to a study presented at Clinical Osteoporosis 2017: A Joint ISCD/NOF Symposium from April 20 to 22 in Orlando, Florida.

The investigators analyzed radiographic assessments with Norland bone age assessment to compare studies and sensitivities to change in children.


Continue Reading

In 1 study, 18 men (aged 12-19 years) and 20 women (aged 12-16 years) underwent radiographic bone age assessment with the GE Discovery XR656 Digital Radiography System and DXA with the Norland XR-800. Regression analysis was used to determine results in the bone age assessment study.

In the sensitivity-to-change study based on the DXA assessment, 34 men aged 6 to 19 years and 37 women aged 6 to 16 years underwent 2 DXA bone assessments with 3 months between studies to account for a possible increase in bone mineral. Participant follow-up results were used to show an increase greater than the least significant change limit: 4.2% for studies with 1.2% precision.

The results showed that the 2 studies had a similar gross response to bone age. The X-ray and DXA assessed bone ages were found to be highly correlated in men (14.5777+0.9287x; r=0.9897; P <.001) and in women (41.2652+0.7619x; r=0.9250; P <.001).

Overall, 17 of the 34 men showed increases >4.2%, and 17 women showed differences <4.2% in the 2 studies. For the 34 women, 15 participants had increases >4.2% and 19 participants showed differences <4.2% in the 2 studies.

“We conclude that Bone Age Assessment Software can be a useful for bone age assessment and can complement traditional radiographic studies when assessment of short-term change in bone age is desired,” the researchers wrote. 

Related Articles

Reference

Sun Y, Wang J, Sanchez T. Bone age assessment by dual energy x-ray absorptiometry. Presented at: Clinical Osteoporosis 2017: A Joint ISCD/NOF Symposium. April 20-22, 2017; Orlando, FL.

This article originally appeared on Endocrinology Advisor